TVTX Return on Tangible Equity | TRAVERE THERAPEUTICS, INC.

TRAVERE THERAPEUTICS, INC. (TVTX) Return on Tangible Equity

2026-06-30: Return Tang Equity 40.60%.
2026-03-31: Return Tang Equity 188.61%.
2025-12-31: Return Tang Equity -2798.03%.
2025-09-30: Return Tang Equity 246.50%.

Complete source-backed return tang equity history.

Available history: 2011-02-28 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	40.60%
2026-03-31	188.61%
2025-12-31	-2798.03%
2025-09-30	246.50%
2025-06-30	231.88%
2025-03-31	319.13%
2024-12-31	715.43%
2024-09-30	260.89%
2024-06-30	161.99%
2024-03-31	593.30%
2023-12-31	-115.66%
2023-09-30	-50.37%
2023-06-30	810.44%
2023-03-31	-1098.55%
2022-12-31	513.15%
2022-09-30	541.94%
2022-06-30	-3371.14%
2022-03-31	-368.59%
2021-12-31	-117.16%
2021-09-30	-158.56%
2021-06-30	-130.67%
2021-03-31	-106.51%
2020-12-31	-296.60%
2020-09-30	-53.38%
2020-06-30	-56.68%
2020-03-31	-152.24%
2019-12-31	-232.20%
2019-09-30	-141.73%
2019-06-30	-120.81%
2019-03-31	-100.20%
2018-12-31	-78.60%
2018-09-30	-85.76%
2018-06-30	-76.45%
2018-03-31	-60.94%
2017-12-31	-55.63%
2017-09-30	-40.90%
2017-06-30	-61.15%
2017-03-31	-58.98%
2016-12-31	-38.39%
2016-09-30	-33.86%
2016-06-30	78.23%
2016-03-31	56.19%
2015-12-31	85.26%
2015-09-30	71.36%
2015-06-30	178.63%
2015-03-31	-202.04%
2014-12-31	83.76%
2014-09-30	89.29%
2014-06-30	90.67%
2014-03-31	224.74%
2013-12-31	107.74%
2013-09-30	429.27%
2013-06-30	220.12%
2013-03-31	496.16%
2012-12-31	392.86%
2012-11-30	20459.92%
2012-08-31	13011.94%
2012-05-31	5633.97%
2011-11-30	23.69%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-2798.03%
2024-12-31	715.43%
2023-12-31	-115.66%
2022-12-31	513.15%
2021-12-31	-117.16%
2020-12-31	-296.60%
2019-12-31	-232.20%
2018-12-31	-65.77%
2017-12-31	-44.95%
2016-12-31	-31.87%
2015-12-31	85.26%
2014-12-31	83.76%
2013-12-31	107.35%
2012-12-31	541.40%
2012-02-29	23.50%
2011-02-28	38.21%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Oruka Therapeutics, Inc. (ORKA)	United States	$5.663B	-43.76
Mirum Pharmaceuticals, Inc. (MIRM)	United States	$5.798B	-8.81
Cogent Biosciences, Inc. (COGT)	United States	$5.450B	-17.61
Gossamer Bio, Inc. (GOSS)	United States	$5.355B	-0.65
PTC THERAPEUTICS, INC. (PTCT)	United States	$5.199B	-177.07
Amneal Pharmaceuticals, Inc. (AMRX)		$6.326B	25.62
Dianthus Therapeutics, Inc. /DE/ (DNTH)	United States	$5.082B	-27.79
Liquidia Corp (LQDA)	United States	$6.347B	51.23
Erasca, Inc. (ERAS)	United States	$5.073B	-19.96
Veradermics, Inc (MANE)	United States	$4.839B